BACKGROUND: Making the differential diagnosis between central fever and infectious fever is critically important among intracerebral hemorrhage patients followed up in intensive care units (ICUs). Serum procalcitonin (PCT) has been found to be a promising biomarker for the initial diagnosis of infection, even before culturing results. OBJECTIVES: To investigate the relationship between PCT and both fever etiologies and C-reactive protein (CRP) levels among critically ill patients with suspected intracerebral hemorrhage. DESIGN AND SETTING: Cross-sectional study in a public university hospital in Elazig, Turkey. METHODS: ICU patients diagnosed with intracerebral hemorrhage and normal procalcitonin levels were included in this study. From clinical assessments and cultures, they were classified as presenting either infectious or central fever. The sensitivity and specificity of PCT and CRP for predicting infection were calculated using a receiver operating characteristic (ROC) curve. RESULTS: There were 98 ICU patients with diagnoses of intracerebral hemorrhage. The median (interquartile range) PCT levels of patients with infectious and central fever were 4 (0.9-11) and 0.1 (0.1-0.4) ng/ml, respectively, with a statistically significant intergroup difference (P < 0.001). The areas under the ROC curve for predicting infectious or central fever PCT and CRP were 0.958 (P < 0.001) and 0.816 (P < 0.001), respectively. A statistically significant positive correlation was detected between PCT and CRP levels in patients with infectious fever (rho: 0.461; P = 0.003), but not in patients with central fever. CONCLUSIONS: PCT can possibly be used as a biomarker to differentiate between infectious and central fever among ICU patients.
INTRODUCTION
In intensive care units (ICUs), delay in diagnosis and treatment increases mortality rates.
Serious infections among ICU patients most commonly consist of respiratory tract infections, followed by urinary system infections, wound site infections and primary bacteremia. 1, 2 Fever in patients hospitalized in ICUs is an important indicator of infection. Despite new treatment alternatives, the infection-related mortality rate remains high. Likewise, clinical findings of fever remain frequent. Moreover, routine laboratory tests are not specific and sometimes may mislead clinicians. Lack of early-phase and specific markers for diagnosing infection cause delays in treatment and unnecessary use of antibiotics. 3 Early diagnosis and appropriate antibiotherapy decrease infection-related morbidity and mortality. 4 Assessment of clinical and laboratory findings constitutes an ideal method for diagnosing infection. Growth of an infectious agent through culturing provides the most important laboratory evidence. However, this method is time-consuming. While awaiting the results from culturing, other diagnostic laboratory parameters such as the levels of procalcitonin (PCT), C-reactive protein (CRP), leukocytes, neutrophils and erythrocyte sedimentation rate (ESR) have been used.
Over recent years, serum PCT has been found to be an important and promising biomarker for making the initial diagnosis of infection. 5 The incidence of fever in ICUs is 23%. 6 Nearly 50% of these cases relate to noninfectious etiologies. The noninfectious causes of fever include bleeding, atelectasis, drug effects, venous thromboembolism and blood transfusion reactions. 7 Another noninfectious type of fever seen in ICUs is central fever in patients diagnosed with intracerebral hemorrhage. 6 Central fever has been defined as emergence of fever in patients with intracerebral hemorrhage without any focus of infection. 8 Any disequilibrium in central thermomodulation relating to neurological damage may cause hyperthermia. 9 In animal models, direct trauma applied to the preoptic nucleus of the hypothalamus has been observed to induce development of hyperthermia within two minutes. 10 Central fever, which is a frequent complication seen in patients with intracerebral hemorrhage, has been seen in 72% of the patients diagnosed with subarachnoid hemorrhage, 37% of traumatic cerebral injuries and 32-37% of patients with a diagnosis of primary intracranial hemorrhage. 6 If central fever seen in patients with intracerebral hemorrhage can be distinguished from manifestations of systemic inflammatory response syndrome (SIRS) due to infection, this will prevent use of inappropriate antibiotherapy and enable initiation of antibiotherapy that is effective for infection-related SIRS. 7 Infectious and noninfectious causes of fever emerging in patients who have been hospitalized in an ICU need to be identified, and treatment should be rapidly instituted. Many studies have demonstrated that PCT levels do not change or only slightly increase in cases of noninfectious inflammation, surgical trauma, uncomplicated infection, autoimmune disease or neoplastic disease. Therefore, PCT can be used as a reliable biomarker for differentiating between bacterial and non-bacterial inflammatory processes. [11] [12] [13] [14] A significant correlation exists between increased PCT levels and greater severity of infection. Plasma PCT concentrations of between 0.5 and 2 ng/ml are deemed to be mildly elevated levels and are interpreted as local infection. PCT levels above 10 ng/ml are considered to be increased levels. PCT levels of up to 100 ng/ml are considered to be very high levels. Very high levels of PCT are seen in severe bacterial infections and in the hyperinflammatory phase of sepsis.
In nonbacterial or nonparasitic diseases, PCT levels are generally below 2 ng/ml. In severe bacterial infections and sepsis, plasma PCT concentrations range between 2 ng/ml and 1,000 ng/ml. 15 
OBJECTIVES
The aim of the present study was to investigate the relationship between PCT levels and both fever etiology and CRP levels among critically ill patients with intracerebral hemorrhage.
Early determination of the etiology of their fever would enable rational use of antibiotics. Furthermore, through diagnosing infections at an early stage, morbidity and mortality would be prevented and there would also be economic gains.
METHODS

Study design and ethics
This cross-sectional study was conducted in accordance with the principles of the Helsinki Declaration and was approved by the local institutional review board (date: August 2, 2016; decision number: 155682). The clinical progression of the patients, including their ICU stay, discharge and death, was also recorded on forms.
Setting and participants
Statistical analysis
The data were analyzed using the IBM Statistical Package for the Social Sciences v22 (SPSS, Inc., Chicago, IL, USA).
The sample size was decided in accordance with a power analysis (significance level of P < 0.05; power analysis 80%). 
RESULTS
A total of 98 patients were admitted to the ICU with a diagnosis of intracerebral hemorrhage. Among these patients, eight (8.16%) had abnormal procalcitonin levels, one (1.02%) had a history of rheumatic disease and 16 (16.32%) were afebrile on the day of admission. Therefore, all these patients were excluded from the study. Forty-five male patients (61.6%) and 28 female patients (38.4%) with a mean age of 55.59 ± 16.04 years (range, 22-87 years) were included in this study (total of 73 patients).
They presented the following conditions: subarachnoid hemorrhage (n = 42; 57.5%), subdural hematoma (n = 15; 20.5%), traumatic subarachnoid hemorrhage (n = 12; 16.4%) and primary intracerebral hemorrhage (n = 4; 5.5%).
Among these 73 patients who were assessed, 39 (53.4%) presented infectious fever and 34 (46.6%) had central fever. (min-max, 5-210); while for those with PCT < 0.5 ng/ml, it was 20 days (min-max, 7-150). In parallel with longer hospital stays, increases in mean serum PCT levels were seen. However, no statistically significant differences were detected (P = 0.051).
The median PCT level of patients who died (n = 28; 38.36%) was 5 ng/ml (IQR, 0.8-18.5). This was significantly higher than that of discharged patients (n = 45; 61.64%), for whom the PCT level was 0.2 ng/ml (IQR, 0.1-0.6) (P < 0.001).
The median CRP level among the patients with infectious fever was 167 mg/l (IQR, 138-201); while the median CRP level of the cases with central fever was 72.5 mg/l (IQR, 16.25-137.7).
A statistically significant positive correlation was detected between PCT and CRP levels in patients with infectious fever (rho: 0.461; P = 0.003) (Figure 1) . However, in cases with central fever, no significant correlation was detected between PCT and CRP levels (rho: 0.239; P = 0.173). In both groups, there were no statistically significant correlations between PCT levels, ESR, blood leukocyte levels and polymorphonuclear leukocyte (PMNL) percentages.
The median white blood cell count, neutrophil count, erythrocyte sedimentation rate, CRP level and PCT level of the cases are presented in Table 2 . A statistically significant difference was detected between the infectious fever and central fever groups regarding PCT level, ESR and CRP level.
To evaluate the sensitivity and specificity of these three biomarkers, ROC curves were calculated. The ROC analysis showed that PCT was a good marker for distinguishing infectious fever patients, with an area under the curve (AUC) of 0.958 (95% confidence interval: 0.912-1.000; P < 0.001). CRP was found to have an AUC of 0.816 (95% confidence interval: 0.714-0.917; P < 0.001). The ESR was found to have an AUC of 0.748 (95% confidence interval: 0.633-0.863; P < 0.001). The sensitivity and specificity of PCT, CRP and ESR for diagnosing infectious fever in cases of intracerebral hemorrhage are presented in Table 3 . ROC curves comparing PCT, CRP and ESR with regard to predicting the diagnosis of infectious fever in cases of intracerebral hemorrhage are shown in Figure 2 . It has been demonstrated that PCT levels enable reliable differentiation of sepsis from SIRS. 17 In both human and animal models, increased levels of PCT production have been demonstrated in situations of bacterial infection. 18 were compared between patients with infectious and central fevers, and increased PCT levels in cases of intracerebral hemorrhage were not found to be specific for the diagnosis of infectious fever. In their study, localized infections, such as sinusitis and enterocolitis, were frequently encountered; however, in our study, higher incidence of secondary bloodstream infections was encountered, which may have been the reason for the relatively higher PCT levels.
A relatively small-scale study in which PCT was investigated as a biomarker of infection was unable to provide adequate and significant information on this issue. 21 In another study, PCT levels were compared between patient groups with sterile meningeal inflammation in Neuro-Behcet's disease and with bacterial meningitis, and no statistically significant difference was found. 22 The differences that have arisen between various studies may have been due to the diverse effects of different types of infection on the production of PCT. Larger-scale studies need to be conducted on this issue.
Several investigations have been performed concerning the use of CRP and PCT levels for diagnosing and following up cases of infection in patients. In most studies, PCT has been reported to be superior to CRP for differentiating between sepsis and SIRS. However, some other studies have not indicated any superiority of PCT. [23] [24] [25] [26] [27] PCT has been found to be 7% more sensitive and 23% more specific than CRP for establishing the diagnosis of bacterial infection. 28, 29 In another study, it was reported that both PCT and CRP could be used in making the diagnosis of infection, but that PCT was superior for determining the prognosis. 30 Ugarte et al. followed up 190 adult ICU patients and diagnosed the presence of hospital-acquired infection in 111 patients.
They compared the patients with and without infection and observed that there were statistically significantly higher PCT and CRP levels in patients with infection. 31 In their study, the best cutoff values for PCT and CRP were 0.6 ng/ml and 7.9 mg/dl, respectively. According to their study, PCT is not a better marker of infection than CRP, among critically ill patients.
In our patients, a statistically significant positive correlation was detected between the PCT and CRP levels in cases with infectious fever. However, this significant correlation was not detected in the central fever group (rho: 0.239; P = 0.173). CRP is classified as an acute-phase reactant, which means that its levels will rise in response to inflammation. A variety of conditions could commonly cause increases in the levels of CRP and other inflammatory markers.
The limitations of the present study included its characteristics of being a single-site study with only a small number of patients. Multi-site studies would enable acquisition of more accurate information. Our study demonstrated that PCT levels can be used to differentiate between infectious and central fevers in patients with intracerebral hemorrhage, with high specificity and predictive values for infection. However, studies with larger numbers of patients need to be conducted in relation to this issue.
CONCLUSIONS
